RT @NatRevDrugDisc: Upcoming market catalysts in Q3 2018, including three first-in-class drugs - migalastat for Fabry disease, ivosidenib…
5,531 followers
74 followers
RT @NatRevDrugDisc: Upcoming market catalysts in Q3 2018, including three first-in-class drugs - migalastat for Fabry disease, ivosidenib…
3,197 followers
RT @NatRevDrugDisc: Upcoming market catalysts in Q3 2018, including three first-in-class drugs - migalastat for Fabry disease, ivosidenib…
4,204 followers
RT @NatRevDrugDisc: Upcoming market catalysts in Q3 2018, including three first-in-class drugs - migalastat for Fabry disease, ivosidenib…